Distraction, Pain, Propofol Injection, Rubbing
Conditions
Keywords
Pain, Modulation
Brief summary
This prospective randomized controlled study will be conducted to evaluate the effects of rubbing and distraction on the incidence and severity of propofol injection pain and compare them with the standard intravenous lidocaine method.
Detailed description
Propofol has become one of the most common anesthetic agents used for sedation, induction, and maintenance of anesthesia because of its unique pharmacological properties. Pain during bolus injection is a major drawback with an incidence as high as 80%-90% in an untreated patient. One of the most effective factors that alleviate the injection pain involves pretreatment with lidocaine. Spinal modulation of pain is explained by the melzack gate control theory, it proposed that stimulation of A beta fibers by touch and vibration, modulate the dorsal horn gate and therefore the nociceptive input from the periphery could be reduced. (5) Regarding the use of this concept for managing propofol pain, only one study was conducted and revealed that rubbing didn't decrease the incidence but significantly decreased the severity of pain. Distraction is a method of removing attention; so, it modifies cognitive pain perceptions by altering nociceptive responses and triggering an internal pain-suppressing system. Therefore, it causes a decrease in the activation of areas in the brain (e.g.: thalamus and insula) which contribute significantly to pain perception. we will combine rubbing and distraction, as methods for spinal and supra-spinal pain modulation, to evaluate their effects on propofol injection pain and compare them with the standard intravenous lidocaine method.
Interventions
OTHERRubbing Distraction
gently touching on proximal part of the IV injection site with the palm of the hand extending to the elbow. This will be started 5 seconds before propofol injection (not mixed with any drug) and continued until loss of consciousness. Also, a mobile video with duration of 10 seconds will be used for distraction and will be started 5 seconds before propofol injection so as to be ended at the time of first pain assessment.
DRUGLidocaine (drug)
lidocaine will be used by mixing it with the propofol before intravenous injection
OTHERSaline
intravenous propofol will be given without mixing with any drug (except for 2 ml saline to ensure blindness of the outcome assessor).
Sponsors
Tanta University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
open label for rubbing distraction group which is the novel approach to be tested in this trial (obviously, participant and pain assessor in the rubbing distraction group can not be blinded). however, lidocaine group and control group patients and their pain assessors are blinded to group assignment. so a final description of (partially blinded study) can be adopted.
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Patients of either sex * American Society Anesthesiologists physical (ASA) status I-II * age between 18-65 years old * undergoing elective surgeries under general anesthesia using Propofol for anesthetic induction.
Exclusion criteria
* Allergy to experimental drugs * Abuse of alcohol, analgesia, or sedative antidepressant * Difficulty in communication * Chronic pain syndromes, thrombophlebitis, neurological disease, and analgesic administration at the time of the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of propofol injection pain | Pain will be evaluated every 5 seconds during the propofol injection until loss of concioussness. The highest pain score will be recorded | Pain will be graded using a four-point scale: 0 = no pain, 1 = mild pain (pain reported only in response to questioning without any behavioral signs), 2 = moderate pain (pain reported in response to questioning and accompanied by a behavioral sign or pain reported spontaneously without questioning), and 3 = severe pain (i.e., strong vocal response or response accompanied by facial grimacing, arm withdrawal, or tears). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Degree of pain | every 5 seconds during injection and the highest value will be recorded. | Pain will be graded using a four-point scale: 0 = no pain, 1 = mild pain (pain reported only in response to questioning without any behavioral signs), 2 = moderate pain (pain reported in response to questioning and accompanied by a behavioral sign or pain reported spontaneously without questioning), and 3 = severe pain (i.e., strong vocal response or response accompanied by facial grimacing, arm withdrawal, or tears) |
| Recall of pain | 1 hour after surgery | Patients who will report pain during propofol injection will be asked if they recalled this pain |
| adverse effects | 1 hour after surgery | Like redness or edema will be examined at the site of propofol injection |
Countries
Egypt
Outcome results
None listed